-
Protocol for a Real-World Retrospective Study on Cardiovascular Outcomes in Japan Comparing Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers
Mar 10, 2025, 14:00 PM -
Economic Impact of Blister-Packaging on Medication Adherence in First-Line Multiple Myeloma Treatment
Mar 10, 2025, 14:00 PM -
Association of Chronic Conditions and Medication Burden with Patient Preferences for Long-Acting Antiretroviral Therapy in HIV Treatment
Mar 10, 2025, 14:00 PM -
A Targeted Literature Review of Value-Based Agreements (VBAs) for Cell and Gene Therapies in the United States
Mar 10, 2025, 14:00 PM -
Economic Evaluation of NT-proBNP Testing to Facilitate Prevention of Heart Failure in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Validity and Accuracy of Asthma-Related ICD-10 Diagnosis Codes in United States Real-World Administrative Database
Mar 10, 2025, 14:00 PM -
Impact of Post-Discharge Rifaximin Use Following an Overt Hepatic Encephalopathy (OHE) Hospitalization on Annual Rates of OHE Rehospitalization in the United States
Mar 10, 2025, 14:00 PM -
Fostering the Identification and Dissemination ofHealth Technology Assessment Studies: The Brazilian HTA Database Case Study
Mar 10, 2025, 14:00 PM -
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Costs in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real World Data
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management
Mar 10, 2025, 14:00 PM -
Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure
Mar 10, 2025, 14:00 PM -
Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals
Mar 10, 2025, 14:00 PM -
DAGDraw: A Responsive and Modern Directed Acyclic Graph Drawing Tool for Causal Inference and Transportability Analysis
Mar 10, 2025, 14:00 PM -
Real-World Biologic Prescribing Patterns and Reasons for Discontinuation in Patients with UC and CD
Mar 10, 2025, 14:00 PM -
Impact of China's NRDL Value-Rating System on Reimbursement and Pricing of Innovative Therapies
Mar 10, 2025, 14:00 PM -
Patient Attitudes and Emotions Predict Health Outcomes: Evidence From the National Health and Wellness Survey
Mar 10, 2025, 14:00 PM -
Hypertension Medication Use and Primary Medication Non-Adherence Among Postpartum Women
Mar 10, 2025, 14:00 PM -
Exploring physicians' Perspectives on the Diagnosis Journey of Rare Diseases in the United States (US): Findings from a Cross Sectional Survey
Mar 10, 2025, 14:00 PM
